Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silver North Intersects 1.83 metres True Width of 1,088 g/t Silver, 3.90 g/t Gold (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Wayland Group Corp MRRCF

Healthcare Biotechnology Drug Manufacturers - Specialty & Generic Cannabis
Wayland Group Corp, formerly Maricann Group Inc produces and sells medical marijuana. It is currently engaged in cultivation, extraction, analytics and production facilities to elevate offerings and prepare for growth into the adult-use cannabis market in Canada.


GREY:MRRCF - Post by User

Wayland Group Corp
Bullboard Posts
User Avatar Image
(0)
•••
Comment by Heresyon Mar 02, 2018 8:03am
102 Views
Post# 27649933

RE:RE:termination of financing was a GIVEN

RE:RE:termination of financing was a GIVENActually they changed the pharmacy part quite a bit. Previously the presentation had a pilot pharmacy project and then a full rollout. There is not as much focus on this part as last month. I think they are just trying to be careful in what is presented. 

Other than that it is it is a great buying opportunity. We do have to wait and see what comes out of the financing and if McKesson backs out from the drama. 

Derthebear wrote: Maricann updated their corporate presentation yesterday and made sure to include pharmacie roll out initiative as well as German expansion and gmp ... One can assume both are still a go ... As for uplisting to the tsx I believe it’s going to de delayed ... 


Bullboard Posts
Dealroom for high-potential pre-IPO opportunities